Apatinib targets both tumor and endothelial cells in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the most commonly diagnosed malignancies worldwide with poor prognosis and tends to be hypervascular. Aberrant expression of the vascular endothelial growth factor 2 (VEGFR‐2) has been implicated in the progression of HCC and represents a valid target for ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Chaoxu, Qin, Shukui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144148/
https://www.ncbi.nlm.nih.gov/pubmed/30109780
http://dx.doi.org/10.1002/cam4.1664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144148/
https://www.ncbi.nlm.nih.gov/pubmed/30109780
http://dx.doi.org/10.1002/cam4.1664

Ejemplares similares